25 related articles for article (PubMed ID: 3815398)
1. Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.
Henwood JM; Brogden RN
Drugs; 1990 Mar; 39(3):438-90. PubMed ID: 2184009
[No Abstract] [Full Text] [Related]
2. Results of phase I-II trial of concomitant hyperfractionated radiation and oral etoposide (VP-16) in patients with unresectable squamous cell carcinoma of the head and neck.
Khafif A; Canfield VA; Syzek EJ; Medina JE
Am J Otolaryngol; 2003; 24(1):1-5. PubMed ID: 12579475
[TBL] [Abstract][Full Text] [Related]
3. Mitoguazone in advanced squamous cell carcinoma of head and neck origin: a phase II trial of the Southeastern Cancer Study Group.
Luedke DW; Maddox W; Birch R; Velez-Garcia E; Schleuter J
Cancer Treat Rep; 1986 Apr; 70(4):529-30. PubMed ID: 3698048
[No Abstract] [Full Text] [Related]
4. Phase II trial of bisantrene in advanced epidermoid carcinoma of the head and neck.
Forastiere AA; Crain SM; Garbino C; Tipping SJ; Perry DJ; Kasdorf H; Van Echo DA
Cancer Treat Rep; 1984 Apr; 68(4):687-8. PubMed ID: 6713424
[No Abstract] [Full Text] [Related]
5. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.
Papadimitrakopoulou VA; Dimery IW; Lee JJ; Perez C; Hong WK; Lippman SM
Cancer J Sci Am; 1997; 3(2):92-9. PubMed ID: 9099459
[TBL] [Abstract][Full Text] [Related]
6. Salvage therapy with oral etoposide in recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Gedlicka C; Kornfehl J; Turhani D; Burian M; Formanek M
Cancer Invest; 2006; 24(3):242-5. PubMed ID: 16809151
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of etoposide in previously untreated squamous cell carcinoma of the head and neck.
Cobleigh MA; Hill JH; Lad TE; Shevrin DE; Applebaum EL
Cancer Treat Rep; 1987 Mar; 71(3):321-2. PubMed ID: 3815398
[No Abstract] [Full Text] [Related]
8. The need for a better prognostic staging system in patients with metastatic cutaneous squamous cell carcinoma of the head and neck.
Palme CE; MacKay SG; Kalnins I; Morgan GJ; Veness MJ
Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):103-6. PubMed ID: 17413411
[TBL] [Abstract][Full Text] [Related]
9. [Epidermoid carcinoma of the head and neck: contribution of chemotherapy in case of recurrence and locally advanced disease. Review of the literature].
Hasbini A; Durdux C; Faivre S; Wasserman E; Taamma A; Armand JP; Raymond E; Cvitkovic E
Ann Otolaryngol Chir Cervicofac; 2000 Dec; 117(6):390-402. PubMed ID: 11148344
[TBL] [Abstract][Full Text] [Related]
10. [Basement membrane laminin in head and neck squamous cell carcinoma and its significance in therapy].
Kuratomi Y
Nihon Jibiinkoka Gakkai Kaiho; 2002 Jun; 105(6):721-6. PubMed ID: 12182149
[No Abstract] [Full Text] [Related]
11. The surgical pathology of head and neck cancer.
Zarbo RJ; Crissman JD
Semin Oncol; 1988 Feb; 15(1):10-9. PubMed ID: 3278387
[No Abstract] [Full Text] [Related]
12. Cell kinetics in squamous cell carcinoma of the head and neck.
Stell PM
Clin Otolaryngol Allied Sci; 1992 Oct; 17(5):444-8. PubMed ID: 1458630
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
